Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients

BACKGROUND: In the absence of antiviral alternatives, interventions under research for COVID-19 might be offered following guidelines from WHO for monitored emergency use of unregistered and experimental interventions (MEURI). Ivermectin is among several drugs explored for its role against SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Marcos Alejandro, Krolewiecki, Alejandro, Ferrero, Alejandro, Bocchio, Marcelo, Barbero, Juan, Miguel, Marcos, Paladini, Ariel, Delgado, Carlos, Ojeda, Juan Ramón, Elorza, Claudia, Bertone, Ana, Fleitas, Pedro Emanuel, Vera, Gustavo, Kohan, Mario Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902036/
https://www.ncbi.nlm.nih.gov/pubmed/35273939
http://dx.doi.org/10.3389/fpubh.2022.813378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902036/
https://www.ncbi.nlm.nih.gov/pubmed/35273939
http://dx.doi.org/10.3389/fpubh.2022.813378

Ejemplares similares